Doris Duke Charitable Foundation

• NCT06358638

  Collaborator, Phase 2, Recruiting, 12 people, 10 Apr 2024

• NCT06212271

  Collaborator, Early phase 1, Completed, 24 people, 18 Jan 2024

• NCT06116526

  Collaborator, Phase 4, Recruiting, 30 people, 3 Nov 2023

• NCT06016634

  Collaborator, Phase 2, Recruiting, 30 people, 30 Aug 2023

• NCT05980156

  Collaborator, Phase 4, Completed, 646 people, 7 Aug 2023

• NCT05705427

  Collaborator, Phase 4, Completed, 317 people, 30 Jan 2023

• NCT05244954

  Collaborator, Phase 4, Completed, 746 people, 17 Feb 2022

• NCT05057806

  Collaborator, Early phase 1, Recruiting, 30 people, 27 Sept 2021

• NCT04828031

  Collaborator, Phase 1, Completed, 48 people, 1 Apr 2021

• NCT04817345

  Collaborator, Phase 2, Withdrawn, 0 people, 26 Mar 2021

• NCT03789591

  Collaborator, Phase 3, Completed, 104 people, 28 Dec 2018

• NCT03128515

  Collaborator, Phase 3, Completed, 187 people, 25 Apr 2017

• NCT02437084

  Collaborator, Phase 4, Completed, 115 people, 7 May 2015

• NCT02365285

  Collaborator, Phase 1/2, Completed, 23 people, 18 Feb 2015

• NCT01976416

  Collaborator, Phase 3, Completed, 208 people, 5 Nov 2013

• NCT01556906

  Collaborator, Phase 2, Completed, 6 people, 19 Mar 2012

• NCT01174056

  Collaborator, Early phase 1, Completed, 39 people, 3 Aug 2010

• NCT00405366

  Collaborator, Early phase 1, Completed, 30 people, 30 Nov 2006

• Adverse pregnancy outcomes and long-term cardiovascular disease risk

  30 Aug 2026

• Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes

  Grant 2023-0214, 14 Aug 2026

• Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

  2023-0224, 8 Aug 2026

• Cytomegalovirus in HIV: A Modifiable Driver of Inflammation, Frailty, and Aging

  2021193, 20 Mar 2026

• Exploring the association between epigenetic age and intensive care unit delirium: a pilot feasibility study

  2023-0240, 10 Mar 2026

• Contrast input and manual interventions significantly affect FreeSurfer morphometry and clinical correlations

  25 Feb 2026

• Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose

  Clinical Scientist Development Award, 7 May 2020

Sources: api.crossref.org

• Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

  Grants or research support, 1 Oct 2026

• Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial

  Grants or research support, 30 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov